“…Using knowledge of isotope resonance through the BADz phenomenon will also allow more efficient poly-isotope correction of metabolic disorders in various diseases by creating conditions for targeted fractionations of isotopes in certain pathological cells and certain focuses of the disease. The latter is relevant because in current medical practice, increasing numbers of different metabolic disorders and cell pathologies are corrected by mostly monoisotopic medicines, especially 2 H-isotope-modified drinking and diet therapies in healing the following diseases and certain conditions: - Alzheimer’s disease was treated by deuterium-reinforced polyunsaturated fatty acids (D-PUFAs), which improved cognition in mice fed a Western-type diet [117], and reduced the brain tissue concentrations of oxidation products and amyloid β-peptide in APP/PS1 mutant transgenic mice [118];
- Parkinson’s disease was partially cured by the administration of D-PUFAs, which protected against nigrostriatal damage (in the substantia nigra) from oxidative injury in mice with a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model [119];
- Mitochondrial disorders and oxidative stress were corrected by both deuterium-depleted water [16,55,56,65,69,120,121] and D-PUFAs, such as 11,11-D(2)-linoleic and 11,11,14,14-D(4)-α-linolenic acids and others, which preserved mitochondrial bioenergetics function under toxic effects of t -butylhydroperoxide, ethacrynic acid, or ferrous iron [122], prevented coenzyme Q (ubiquinone or CoQ)-less coq mutants and some toxic effects of lipid autoxidation products [123,124,125], and also decelerated the aging process by deuterated trilinolenin (D-TG (54:9)), resulting in extended lifespan of worms under normal and oxidative stress conditions [126];
- Cerebral hypoxia was corrected by deuterium-depleted water, the long-term consumption of which resulted in activation of neuron protective systems, with higher antioxidant activity in brain tissues [68,75];
- Friedreich’s ataxia was treated by deuterated linoleic and α-linolenic acids, which resulted in rescue of oxidative-stress-challenged cells by decreasing lipid peroxidation [127], and also deuterated ethyl linoleate (RT001), which recovered mitochondrial function [128];
- Huntington’s disease was managed by D-PUFA diet in Q140 knock-in mice, which were able to demonstrate improved performance in novel object recognition tests after 5 months of consumption of deuterium-enriched diet [129];
- Cancer adjuvant therapy showed efficacy through the administration of 1 H 2 O [22,70,130,131], and previously-drug-processed gliomas was treated by combining deuterium...
…”